4/12/23 19:05 | 4/12/23 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Myers Scott Dunseth | MA | DO | CEO | P | 101 | 25.37 | 0 | 4 | 2 | 260 | D | | | | | | | | | | | | | | |
3/13/23 16:06 | 3/13/23 | VRDN | Viridian Therapeutics, Inc.de | DE | Health | Health | Medical Laboratories | Myers Scott Dunseth | MA | DO | CEO | P | 160 | 29.15 | 0 | 6 | 2 | 256 | D | | | | | | | | | | | | | | |
1/16/18 17:26 | 1/11/18 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | M.d | 0 | 0.00 | 0 | 11 | 23 | 57 | D | | | | | | | | | | | | | | |
8/14/17 17:12 | 8/11/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 21 | 3.74 | 0 | 6 | 12 | 50 | D | | | | | | | | | | | | | | |
5/16/17 17:43 | 5/12/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 11 | 4.00 | 1 | 3 | 7 | 44 | D | -53 | -32 | -36 | 1 | 1 | 0 | -2 | 7 | | | | | | |
4/4/17 17:39 | 3/31/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 8 | 4.11 | 1 | 2 | 5 | 41 | D | -59 | -43 | -59 | -7 | -7 | -3 | 3 | -3 | -3 | 1 | 9 | | | |
3/21/17 20:09 | 3/20/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 4 | 3.93 | 1 | 1 | 3 | 39 | D | -63 | -49 | -49 | -25 | -12 | -8 | -6 | -2 | 7 | 13 | 8 | | | |
1/31/17 16:55 | 1/27/17 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 77 | 3.76 | 2 | 21 | 114 | 38 | D | -56 | -47 | -37 | -38 | -20 | -16 | 11 | 11 | 2 | 7 | 3 | 3 | | |
8/18/16 17:16 | 8/17/16 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 52 | 1.15 | 0 | 45 | 72 | 108 | D | -60 | -65 | 8 | -2 | 20 | 1 | 3 | 4 | 1 | 2 | 12 | 0 | -38 | |
6/28/16 17:36 | 6/28/16 | CASC | Cascadian Therapeutics, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Myers Scott Dunseth | WA | DO | P,CEO | P | 50 | 0.8000 | 2 | 63 | New | 63 | D | -74 | -77 | -64 | -21 | -20 | -26 | -10 | 2 | 9 | 5 | 26 | 77 | -13 | |
5/26/06 13:50 | 5/24/06 | DOVP | Dov Pharmaceutical Inc | DE | Health | Drug | Pharmaceutical Preparations | Myers Scott Dunseth | NJ | O | SVP | P.m | 27 | 2.69 | 0 | 10 | New | 10 | | | | | | | | | | | | | | | |